These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 9203067)
21. Vigabatrin in uncontrolled seizures: Belgian clinical experience. The Belgian Vigabatrin Evaluation Group. Lhoir A Clin Neurol Neurosurg; 1994 Feb; 96(1):42-6. PubMed ID: 8187381 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of West syndrome]. Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352 [TBL] [Abstract][Full Text] [Related]
23. Vigabatrin in childhood epilepsy: a 5-year follow-up study. Uldall P; Alving J; Gram L; Høgenhaven H Neuropediatrics; 1995 Oct; 26(5):253-6. PubMed ID: 8552215 [TBL] [Abstract][Full Text] [Related]
24. Dose-response study of vigabatrin in children with refractory epilepsy. Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124 [TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of the effectiveness and safety of vigabatrin]. Jedrzejczak J; Owczarek K Neurol Neurochir Pol; 2000; 34 Suppl 1():177-85. PubMed ID: 10768157 [TBL] [Abstract][Full Text] [Related]
26. The role of vigabatrin in childhood seizure disorders: results from a clinical audit. Prasad AN; Penney S; Buckley DJ Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785 [TBL] [Abstract][Full Text] [Related]
27. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs. Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563 [TBL] [Abstract][Full Text] [Related]
28. Vigabatrin in childhood epilepsy: comparable efficacy for generalized and partial seizures. Sheth RD; Buckley D; Penney S; Hobbs GR Clin Neuropharmacol; 1996 Aug; 19(4):297-304. PubMed ID: 8828992 [TBL] [Abstract][Full Text] [Related]
29. Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Grant SM; Heel RC Drugs; 1991 Jun; 41(6):889-926. PubMed ID: 1715266 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy. Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420 [TBL] [Abstract][Full Text] [Related]
33. Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients. Murri L; Iudice A Acta Neurol Scand Suppl; 1995; 162():40-2. PubMed ID: 7495189 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy. You SJ; Jung DE; Kim HD; Lee HS; Kang HC Eur J Paediatr Neurol; 2008 Jul; 12(4):314-20. PubMed ID: 17951084 [TBL] [Abstract][Full Text] [Related]
35. Vigabatrin: new indication. An advance in infantile spasms. Prescrire Int; 1998 Apr; 7(34):43-4. PubMed ID: 10183381 [TBL] [Abstract][Full Text] [Related]
36. Vigabatrin in partial seizures in children. Nabbout RC; Chiron C; Mumford J; Dumas C; Dulac O J Child Neurol; 1997 Apr; 12(3):172-7. PubMed ID: 9130090 [TBL] [Abstract][Full Text] [Related]